【Member News】After a Decade in Women’s Reproductive Health, Duofu Consulting's Director Guo Jialin Shares Global Strategy and Full-Cycle Services at World Reproductive Conference

On September 5, 2025, the 7th Global Assisted Reproduction Exchange Conference concluded successfully in Guangzhou. As an important part of focusing on "Cross-border Reproductive Services and Women's Full Cycle Health", Ms. Guo Jialin, Director of Duofu (Beijing) Business Consulting Co., Ltd.(referred to as "Duofu Overseas"), was invited to deliver a special speech entitled "Duofu's Strategic Layout at Home and Abroad: Femal-centered Assisted Reproductive Full Cycle Service Practice". Relying on Duofu Overseas's ten years of in-depth experience in the industry, Director Guo Jialin systematically elaborated the integrated strategy of "cross-border reproduction + domestic medical care + women's health management" for the first time from the four dimensions of corporate development history, market insight, core service advantages and future planning., providing the industry with an innovative model of "linkage of domestic and foreign resources and full-cycle service escort", which attracted widespread attention from the guests present.

Ten years of deep cultivation: The evolutionary path from cross-border medical care to closed-loop female reproductive health

At the beginning of the speech, Director Guo Jialin used a Timeline as a context to sort out the development trajectory of Duofu Overseas, showing its transformation from a single cross-border service to a comprehensive reproductive health platform:

· 2014: Starting from "Medre Overseas Medical Care", we set foot in Japanese physical examinations, Swiss anti-aging, overseas consultations for difficult and miscellaneous diseases, and accumulated cross-border service experience for follow-up reproductive medical layout;

· 2015: Duofu Overseas was officially established, focusing on core businesses such as reproduction and IVF in the United States, and opening a deep track for women's reproductive health;

· 2016-2018: Accelerate global layout and establish a Russian service team; simultaneously expand the domestic market, establish its own reproductive hospital, and reach strategic cooperation with a number of high-end insurance and private banks to serve high-net-worth people;

· 2020-2022: Consolidating the foundation of domestic medical care, its domestic hospitals successfully obtained reproductive licenses, and establishing in-depth cooperation with domestic top-three hospitals to achieve a two-way linkage of "overseas resources + domestic diagnosis and treatment";

· 2024-2025: Strategic upgrade, reaching cooperation with Hainan Boao Yongxing Hospital to jointly build the Aiyuhua International Department, further improving the "domestic and overseas integration" service network, and forming a female reproductive health service covering "prevention-diagnosis and treatment-rehabilitation". Closed loop.

"In the past ten years, we have witnessed the rapid growth of the assisted reproduction market in China, and we have always taken 'accompanying women's reproductive health throughout their life cycle' as our original intention." Director Guo Jialin emphasized that every step of development of Duofu Overseas is closely related to user needs-from initially solving "cross-border medical difficulties" to now providing "full-cycle health management", just to enable women to obtain professional reproductive health support at different stages of their lives.

Market insight: Duofu's differentiated service path with the needs of 50 million couples

In his speech, Director Guo Jialin combined data from authoritative organizations such as Sullivan to conduct an in-depth analysis of the current situation of the assisted reproduction market in China and the pain points of user needs, providing data support for Duofu Overseas's strategic layout:

The market scale continues to expand, and there is still huge room for penetration.

In 2020, the size of the assisted reproduction market in China has reached 43.4 billion yuan, and is expected to increase to 85.4 billion yuan in 2025, with a compound annual growth rate of 14.5%. However, the IVF (in vitro fertilization) market penetration rate has only increased from 7% in 2018 to 9.2% in 2023, far lower than the 30.2% in the United States, and the market potential is huge. "This gap not only reflects the challenges on the technology supply side, but also provides us with opportunities for differentiated services." Director Guo Jialin said.

2. Infertility rates rise, and demand for high-net-worth people escalates

It is predicted that the infertility rate in China will exceed 18% in 2023, involving about 50 million couples. Environmental pollution, delayed childbearing age, and lifestyle changes are the main triggers. At the same time, the demand for "eugenics and childcare","cross-border medical options" and "full-cycle service experience" among high-net-worth people has become increasingly prominent-they not only pay attention to the success rate of IVF, but also pay attention to preoperative ovarian maintenance, postoperative psychological counseling, and full-chain experience such as convenience of cross-border processes.

3. Accurately match needs and create a hierarchical service system

In response to the different needs of different user groups, Duofu Overseas has built a refined service matrix:

·High-net-worth intended parents: Provide in-depth content such as legal protection for surrogacy in the United States and detailed explanation of high-end cross-border medical procedures through channels such as Zhihu and Weixin Official Accounts, emphasizing "legal certainty" and "service privacy";

·Budget-sensitive families: Share cost comparisons and success stories from Thailand, Canada and other regions in Xiaohongshu and communities, and provide cost-effective cross-border reproductive solutions;

·All intended customers: Reduce the decision-making threshold through one-on-one consultation on the official website, videos of customer success stories, online lectures and other forms to ensure transparency and controllability throughout the service process.

"Our core KPIs are always set around the user experience." Director Guo Jialin shared that Duofu Overseas's customer acquisition cost (CPA) is controlled within US$5000, the conversion rate from consultation to signing exceeds 50%, the customer satisfaction (CSAT) reaches more than 90%, and the net recommendation value (NPS) exceeds 50. All indicators are at the industry-leading level.

Core advantages: domestic and overseas linkage + full-cycle services to solve reproductive health pain points

In the core part of the speech, Director Guo Jialin explained in detail the "three core advantages" of Duofu Overseas and demonstrated its competitiveness in the field of assisted reproduction:

1. Deep integration of domestic and foreign resources to achieve "two-way empowerment"

Duofu Overseas has established a service network of "overseas high-quality medical resources + domestic diagnosis and treatment guarantee": overseas, cooperating with top reproductive institutions in the United States, Russia and other countries to provide advanced PGS/PGD (third generation IVF) technology and legal surrogacy support; domestic, relying on its own reproductive hospital, third-class cooperative resources and policy advantages of Hainan Boao Medical Pioneer Zone, it provides localized services such as preliminary examination, ovarian maintenance and postoperative follow-up for users.

"For example, a customer who plans to go to the United States to do IVF can complete the preliminary ovarian function assessment and basic examination in China, and then connect with the American clinic through our cross-border service team. After returning home after surgery, the domestic hospital will provide guidance on fetal protection and postpartum rehabilitation to realize 'seamless connection'." Director Guo Jialin gave an example to explain that this mode not only solves the cumbersome process of cross-border medical treatment, but also reduces the time and economic cost of users.

2. Focus on women's full cycle, providing "refined health management"

Different from traditional reproductive institutions that only focus on the "test-tube cycle", Duofu Overseas extends its services to the entire life cycle of women's reproductive health:

· IVF full-cycle support: Provide guidance on drugs, health products and psychological counseling before surgery, simultaneously follow up diagnosis and treatment plans during surgery, monitor hormone levels after surgery, and provide advice on preventing pregnancy;

·Dynamic management of ovarian function: Customize personalized maintenance plans for changes in different stages of high, medium and low ovarian function, such as delaying ovarian decline through nutritional intervention and lifestyle guidance;

·Intervention during decline: Provide women with declining ovarian function with a comprehensive treatment plan combining surgery, drugs and products to maximize their fertility potential.

"We are not only concerned about 'whether we can get pregnant,' but also 'women's health and experience throughout the process'." Director Guo Jialin emphasized that Duofu Overseas's service team includes doctors, nutritionists, and psychological counselors, which can provide multi-dimensional support to users.

3. Data-driven operations to improve service efficiency and security

Duofu Overseas introduces the Internet hospital system and AI analysis technology to optimize service processes through data management:

·Intelligent matching: Use AI to analyze user needs (such as age, ovarian reserve, budget) and accurately recommend overseas clinics or domestic hospitals. The average matching time is controlled within 90 days;

·Risk management and control: Establish a cycle cancellation rate monitoring mechanism to control the cycle cancellation rate before embryo transfer to below 3%(normal responders), which is far lower than the industry average;

·Single course management: Through services such as Green Pass registration, full follow-up by doctor assistants, and psychological support, we ensure that users can receive timely guidance at each diagnosis and treatment node.

Future planning: Work hard in three directions to build a new ecology of women's health

At the end of the speech, Director Guo Jialin announced Duofu Overseas's future strategic plan, clarifying three major development directions:

1. Create a "closed loop on women's health" and expand service boundaries

With assisted reproduction as the core, it integrates fertility preservation, ovarian maintenance, postpartum rehabilitation and other services to form a full chain of services of "prevention-diagnosis and treatment-rehabilitation-maintenance", covering women's reproductive health needs from adolescence to menopause. "In the future, we will not only be a 'fertility aid institution', but also a' female reproductive health steward.'

2. Build an "assisted reproduction platform" to achieve efficient docking of resources

It plans to build an open assisted reproductive service platform, integrate high-quality medical resources, insurance institutions, and health management service providers at home and abroad, provide users with standardized service packages with "low-risk, short cycle, and reasonable profits", and at the same time provide resource docking support for small and medium-sized institutions. Promote the standardized development of the industry.

3. Deepen "data-based operations" and improve service accuracy

Further improve the AI analysis system and single course management system, optimize the plan recommendation algorithm through the accumulation of user diagnosis and treatment data; at the same time, strengthen cooperation with domestic top-three hospitals and scientific research institutions to carry out clinical research related to reproductive health and provide scientific support for service upgrades.

"In the future, Duofu Overseas will continue to be 'women-centered' and allow more women to receive professional and warm reproductive health support through resource linkage and full-cycle services at home and abroad." Director Guo Jialin extended an invitation at the end of his speech and looked forward to working with industry partners to jointly promote the high-quality development of the assisted reproduction industry in China.

If you want to know about Duofu Overseas's cross-border reproductive services, domestic diagnosis and treatment resources or female reproductive health management solutions, you can pay attention to Duofu Overseas's official channels and obtain one-on-one exclusive services. Duofu Overseas will always stand side by side with you to protect every fertility dream!